Cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia
Europe & Central Asia: Cause of death, by non-communicable diseases, ages 60+, male was 75.0% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia is 75.0%, measured in 2021. That is the lowest value across all 6 years on record.
The figure is down 5.9% on the previous year and down 19.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia peaked at 93.1% in 2010 and was at its lowest, 75.0%, in 2021.
Europe & Central Asia ranks 13th of 47 groups on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia, year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 92.5% | — |
| 2010 | 93.1% | +0.6% |
| 2015 | 92.3% | -0.9% |
| 2019 | 92.1% | -0.3% |
| 2020 | 79.6% | -13.5% |
| 2021 | 75.0% | -5.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.5% | 92.5% | 92.5% | 1 |
| 2010s | 92.5% | 92.1% | 93.1% | 3 |
| 2020s | 77.3% | 75.0% | 79.6% | 2 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0351 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 0.3995 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per capita 0.0355 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia?
- Cause of death, by non-communicable diseases, ages 60+, male in Europe & Central Asia was 75.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in Europe & Central Asia?
- The highest recorded value was 93.1% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in Europe & Central Asia?
- The lowest recorded value was 75.0% in 2021.
- How does Europe & Central Asia rank for cause of death, by non-communicable diseases, ages 60+, male?
- Europe & Central Asia ranks 13th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in Europe & Central Asia?
- Over the last ten years it is down 19.5%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.